Kesimpulan KESIMPULAN DAN SARAN
DAFTAR PUSTAKA
Albert, P., 2008, Drug-Drug Interaction in Pharmaceutical Development, John Wiley and Sons, USA, pp.1-5.
Aller et al, 2009, Structure of P-glycoprotein Reveals a Molecular Basis for Poly- Specific Drug Binding, NIH Public Access, 1718-1722
Angger, R., 2007, Kerasionalan Pengobatan Tuberkulosis Paru Pada Pasien Dewasa Di Instalasi Rawat Jalan RS Bethesda Yogyakarta Tahun 2005 Yang
Mengacu Pada Standar Penanggulangan Tuberkulosis Depkes RI Dan Standar WHO, Skripsi, Fakultas Farmasi, Universitas Sanata Dharma,
Yogyakarta.
Aschenbrenner, D.S., and Venable, S.J., 2009, Drug Therapy in Nursing, 3
rd
edition, Lippincott Williams and Wilkins, Philadelphia, pp.61-63.
Becker, D.E., 2011, Advers Drug Interactions, Anesth Prog, Dayton, Oiho, 31-40 Baxter, K., 2010,
Stokley’s Drug Interactions, Ninth edition, Pharmaceutical Press,
China, pp. 13-15. Chairns, D., 2006, Intisari Kimia Farmasi, Edisi 2, Penerbit Buku Kedokteran EGC,
Jakarta, hal: 103. Chelmow, D., Geibel, J., Grimm, L., Harris, J.E., Maron, D.J., Meyers, A.D., et al.,
Drug Interaction Checker, Medscape, http:reference.medscape.comdrug- interactionchecker, diakses tanggal 6 Agustus 2014
Citraningtyas, S., 2009, Evaluasi Pengobatan Pada Pasien Tuberkulosis Anak Di Balai Kesehatan Paru Masyarakat Magelang Kunjungan Pertama Januari-
April 2007, Skripsi, Fakultas Farmasi, Universitas Sanata Dharma, Yogyakarta.
Departemen Kesehatan Republik Indonesia, 2005, Pharmaceutical Care Untuk Penyakit Tuberkulosis, Direktorat Bina Kefarmasian dan Alat, Kesehatan
Departemen Kesehatan RI, Jakarta, hal: 60-70. Departemen
Kesehatan Republik
Indonesia, 2007,
Pedoman Nasional
Penanggulangan Tuberkulosis, Departemen Kesehatan RI, Jakarta, hal: 3- 8.
Departemen Kesehatan
Republik Indonesia,
2011, Pedoman
Nasional Penanggulangan Tuberkulosis, Departemen Kesehatan RI, Jakarta, hal: 6-
29.
Departement of Medicine Indiana University, 2009, Drug Interactions, Indiana University, 1-2
Dinas Kesehatan Kabupaten Bantul, 2012, Profil Kesehatan Kabupaten Bantul, http:dinkes.bantulkab.go.idprofil-2012, diakses pada tanggal 25 Februari
2014. Dipiro J., Dipiro C., Wells B., Schwinghammer T., 2008, Pharmacoterapy
Handbook, Seventh Edition, Mc Graw Hill Company, Columbia, pp. 532- 543.
Dooley, Flexner, and Andrade, 2008, Drug Interactions Involving Combination Antiretroviral Therapy and Other Anti-Infective Agents: Repercussions for
Resource-Limited Countries, The Journal of Infection Disease, 1-14 Hacker, M., Bachmann, K. and Messer, W., 2009, Pharmacology Principles and
Practice, Elsevier Inc, USA, pp. 304,305. Hansten, P.D. and Horn, J.R., 2002, Managing Clinically Important Drug
Interactions, Facts and Comparisons, USA, pp. 433, 594, 569-570. Hardjoeno, H. 2007. Kumpulan Penyakit Infeksi dan Tes Kultur Sensitifitas Kuman
serta Upaya Pengendaliannya. Bagian Patologi Klinik FK-UNHAS. Makassar, hal: 1-10.
Hasanmihardja, M., Sudirman, I., Raharjo, B., Nurmila, R., 2007, Kombinasi Obat Antitubekulosis Pada Pasien Anak Rawat Jalan Askes di RSUD Prof.
Margono Soekarjo, Laporan Penelitian, Fakultas Farmasi, Universitas Muhamadiyah, Purwokerto.
Kapadia, J., Thakor, D., Desai, C. and Dikshit, R. K., 2013, A Study of Potential Drug-Drug Interactions in Indoor Patients of Medicine Department at a
Tertiary Care Hospital, Journal of Applied Pharmaceutical Science Vol. 3, 1-8.
Kumar, V., Abbas, A.K., Fausto, N. and Mitchell, R.N., 2007, Robbins Basic Pathology, Eighth Edition, Elsevier, China, pp. 778-780.
Lee et al, 2013, Screening of Genetic Polymorphims of CYP3A4 and CYP3A5 Genes, Korean J Physiol Pharmacol, 478-484
Lusiana, 2006, Penatalaksanaan Penyakit Tuberkulosis Paru Di Puskesmas- Puskesmas Temanggung Peiode Januari-Desember 2005, Skripsi, Fakultas
Farmasi, Universitas Sanata Dharma, Yogyakarta.